Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PPH
#7389
VanEck Pharmaceutical ETF
104.0
8
USD
+0.34%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.34%
Monthly Change
-0.77%
6 month change
+13.79%
Year Change
+24.45%
Previous Close
103.7
3
Open
104.0
0
Bid
Ask
Low
103.9
9
High
104.1
7
Volume
16
Markets
US Stock Market
Financial
PPH
Open full chart
Top holdings
Market Value
Shares
Weight %
LLY
Eli Lilly & Co
265.54 M
247.08 K
20.79%
NVS
Novartis AG
128.27 M
930.35 K
10.04%
MRK
Merck & Co Inc
113.68 M
1.08 M
8.90%
NVO
Novo Nordisk A/S
82.37 M
1.62 M
6.45%
State Street Global Advisors
71.68 M
71.68 M
5.61%
PFE
Pfizer Inc
59.28 M
2.38 M
4.64%
BMY
Bristol-Myers Squibb Co
58.18 M
1.08 M
4.55%
ABBV
AbbVie Inc
56.05 M
245.32 K
4.39%
GSK
GSK PLC
55.96 M
1.14 M
4.38%
MCK
McKesson Corp
55.72 M
67.93 K
4.36%
AZN
AstraZeneca PLC
55.49 M
603.66 K
4.34%
SNY
Sanofi SA
55.47 M
1.14 M
4.34%
JNJ
Johnson & Johnson
55.35 M
267.46 K
4.33%
COR
Cencora Inc
50.63 M
149.91 K
3.96%
ZTS
Zoetis Inc
44.48 M
353.49 K
3.48%
HLN
Haleon PLC
38.32 M
3.79 M
3.00%
TEVA
Teva Pharmaceutical Industries Ltd
33.26 M
1.07 M
2.60%
TAK
Takeda Pharmaceutical Co Ltd
33.00 M
2.12 M
2.58%
VTRS
Viatris Inc
9.54 M
766.14 K
0.75%
Jazz Pharmaceuticals PLC
8.09 M
47.56 K
0.63%
News
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
Oil Shock Meets Asset Price Deflation
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
Europe’s Last Chance To Revive Its Pharmaceutical Innovation Power
Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals